Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Volunteers

NCT00977626 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Part 1 - AZD2423 or Placebo
DRUG: Part 2 - AZD2423
DRUG: Part 3 - AZD2423

Sponsor

AstraZeneca